BALPHARMA.NS · Bal Pharma Limited
India · RS rating 77 · As of 2026-10-14
| Price | 98.44 INR |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 77 / 31 / 80 / 78 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 45 / 33 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -68.6% |
| Sales growth Q/Q | +5.4% |
| Distance from 52-week high | +14.0% |
| Market cap (USD) | $15.6M |